vutrisiran ATTR Amvuttra
Selected indexed studies
- Vutrisiran: First Approval. (Drugs, 2022) [PMID:35997942]
- Vutrisiran: A Review in Polyneuropathy of Hereditary Transthyretin-Mediated Amyloidosis. (Drugs, 2023) [PMID:37728865]
- A mutation in transthyretin gene in a Mexican patient leading to hereditary amyloidosis: a case report. (J Med Case Rep, 2025) [PMID:40760461]
_Worker-drafted node — pending editorial review._
Connections
vutrisiran ATTR Amvuttra treats
Sources
- Vutrisiran: A Review in Polyneuropathy of Hereditary Transthyretin-Mediated Amyloidosis. (2023) pubmed
- Vutrisiran: First Approval. (2022) pubmed
- A mutation in transthyretin gene in a Mexican patient leading to hereditary amyloidosis: a case report. (2025) pubmed
- PMID:42118893 (2026) pubmed
- PMID:42184310 (2026) pubmed